Project information
Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
- Project Identification
- MSM0021622430
- Project Period
- 1/2007 - 12/2013
- Investor / Pogramme / Project type
-
Ministry of Education, Youth and Sports of the CR
- Research Intents
- MU Faculty or unit
- Faculty of Medicine
- Other MU Faculty/Unit
- Faculty of Science
- Other MU Faculty/Unit
- Faculty of Informatics
- Other MU Faculty/Unit
- Central European Institute of Technology
- Keywords
- embryonic stem cells
The goal of this project will be a) to profit from availability of unique cellular resources - mouse and human embryonic stem cells and normal and malignant hematopoietic stem/progenitor cells, b) to effectively employ a wide variety of current and complementary methodologies available to the consortium, and c) to exploit a proven/certified expertise in working with various living systems that span from in vitro cultured cells, through animal models to oncohematological patients. All this together will represent a powerful experimental platform aimed at addressing a nature of molecules and molecular mechanisms underlaying phenomena that are common to both normal and cancer stem cells, mainly their ability to self-renew and to enter differentiation pathways. Integral part of this general goal is to implement multifaceted analytical approach that will cover studies of gene expression at both mRNA and protein levels, evaluating function of extra and intracellular signaling pathways, and analyzing biological properties of cells in vitro and in vivo. Expected outcome will be not only understanding but also a definition of molecules and/or molecular pathways to be tested as therapeutic targets, and cellular models that will make such testing feasible.
Publications
Total number of publications: 357
2013
-
AggreWell plate aggregation and defined factors allow highly uniform-sized and functional cardiac embryoid bodies from human ESCs and iPSCs
Year: 2013, type: Conference abstract
-
Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR-ABL kinase inhibition.
American Journal of Hematology, year: 2013, volume: 88, edition: 5, DOI
-
Are mutations in the IDH2 gene suitable molecular markers for MRD monitoring in AML patienst?
Year: 2013, type: Conference abstract
-
Artificial neural networks in medical diagnosis
Year: 2013, type:
-
Cell cycle regulation in human embryonic stem cells: links to adaptation to cell culture
Experimental Biology and Medicine, year: 2013, volume: 238, edition: 3, DOI
-
C-flip protects human pluripotent stem cells from trail induced apoptosis
Year: 2013, type: Appeared in Conference without Proceedings
-
Clonal heterogeneity in patients with cytogenetically normal acute myeloid leukemia with NPM1 mutations
Leukemia & Lymphoma, year: 2013, volume: 54, edition: 5, DOI
-
Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2
PLOS ONE, year: 2013, volume: 8, edition: 10, DOI
-
Cultivation-dependent plasticity of melanoma phenotype
TUMOR BIOLOGY, year: 2013, volume: 34, edition: 6, DOI
-
Decrease in Abundance of apurinic/apyrimidinic Endonuclease Causes Failure of Base Excision Repair in Culture-Adapted Human Embryonic Stem Cells
Stem Cells, year: 2013, volume: 31, edition: 4, DOI